Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

Suchergebnisse filtern
Datenmodelle auswählen

Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

25 Suchergebnisse.

Radiation Therapy Oncology Group Pathology Submission Form NCT00023829 - Radiation Therapy NCT00023829 Oncology Group Pathology Submission Form

- 03.06.15 - 1 Formular, 3 Itemgruppen, 18 Datenelemente, 1 Sprache

Itemgruppen: RTOG clinical trial administrative data, Pathology submission, CCRR MODULE

Radiation Therapy Oncology Group Pathology Submission Form NCT00023829 Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A46CFF7E-9D16-2C2B-E034-080020C9C0E0

Prostate Cancer Radiation Therapy Calculation Form RTOG NCT00023829 - Radiation Therapy Calculation Form Prostate Cancer NCT00023829

- 20.05.15 - 1 Formular, 2 Itemgruppen, 27 Datenelemente, 1 Sprache

Itemgruppen: Header, Radiation therapy

T4 Radiation Therapy Oncology Group Protocol Calculation Form Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer NCT00023829 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A4E27DE7-685D-26F8-E034-080020C9C0E0

Hypofractionated Radiotherapy in Prostate Cancer NCT01368055 - Eligibility Criteria

- 15.03.21 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01368055

NCT00103181 NSABP Protocol B-39 Radiation Therapy Report for Patients Randomized to PBI (Group 2 Patients Only)

- 05.07.15 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Header, Radiation Therapy Report

NCT00103181 NSABP Protocol B-39 Radiation Therapy Report for Patients Randomized to PBI (Group 2 Patients Only) Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E74A3E53-F9E9-58E3-E034-0003BA3F9857

CALGB: ADJUVANT RADIOTHERAPY REPORT FORM 2 NCT00041119

- 21.06.15 - 1 Formular, 3 Itemgruppen, 16 Datenelemente, 1 Sprache

Itemgruppen: Header, Patient demographics, Radiation Treatment

CALGB: ADJUVANT RADIOTHERAPY REPORT FORM 2 NCT00041119 Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E03851EE-EEDC-5498-E034-0003BA12F5E7

CALGB: 49808 RADIOTHERAPY REPORT FORM NCT00016276

- 03.06.15 - 1 Formular, 4 Itemgruppen, 25 Datenelemente, 1 Sprache

Itemgruppen: CALGB clinical trial administrative data, Patient clinical trial data, RADIATION TREATMENT, Comments

CALGB: 49808 RADIOTHERAPY REPORT FORM NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-8724-227A-E034-080020C9C0E0

NSABP Protocol B-35 Radiation Therapy Report NCT00053898

- 03.06.15 - 1 Formular, 4 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Header Module, adjuvante radiatio status, Breast, Operative Area Boost

NSABP Protocol B-35 Radiation Therapy Report NCT00053898 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A01A1AE7-8AF7-36F3-E034-080020C9C0E0

CALGB: ADJUVANT RADIOTHERAPY REPORT FORM NCT00024102

- 03.06.15 - 1 Formular, 4 Itemgruppen, 16 Datenelemente, 1 Sprache

Itemgruppen: CALGB Information, Patient clinical trial data, Radiation Treatment, CCRR MODULE

CALGB: ADJUVANT RADIOTHERAPY REPORT FORM NCT00024102 Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50C8257-093C-33B9-E034-080020C9C0E0

Breast Cancer Radiation Therapy Report NSABP B-36 NCT00087178 - Radiation Therapy Report Breast Cancer NCT00087178

- 20.05.15 - 1 Formular, 4 Itemgruppen, 17 Datenelemente, 1 Sprache

Itemgruppen: Header, Radiation therapy, Whole Breast Irradiation, Chest Wall Irradiation

NSABP Protocol B-36 Radiation Therapy Report Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer NCT00087178 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C87B5190-AA07-59CE-E034-0003BA12F5E7

Breast Cancer NCT01272037 Treatment - S1007 Radiation Therapy Form (S1007RAD) - 3139641v1.0 - S1007 Radiation Therapy Form (S1007RAD)

- 09.01.15 - 1 Formular, 6 Itemgruppen, 30 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Radiation Therapy, Site Irradiated, Targeted Regions of Treatment, Partial Breast Irradiation Method, Comments

S1007 Radiation Therapy Form (S1007RAD) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90C9DFFB-2367-84DB-E040-BB89AD437DC2

Initial Follow-up Form Prostate Cancer (NCT00288080)

- 07.01.15 - 1 Formular, 7 Itemgruppen, 66 Datenelemente, 1 Sprache

Itemgruppen: Header, Vital Status, Progression, PROSTATE: PSA MEASUREMENTS, Treatment Schedule (LHRH Agonist), TREATMENT SCHEDULE (ORAL ANTIANDROGEN), Non-protocol Therapy

RTOG 0521 FO: Radiation Therapy Oncology Group Phase III Randomized Study of Localized, High-Risk Prostate Cancer Initial Follow-up Form Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer NCT00288080 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0CB07BEA-FAB7-6032-E044-0003BA3F9857

Gamma H2AX DNA Repair During Prostate Cancer Radiotherapy NCT01899391 - Eligibility Criteria

- 22.05.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Pilot Study of Gamma H2AX DNA Repair Foci Kinetics in Peripheral Blood Lymphocytes During Prostate Cancer Radiotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT01899391

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.